ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2414

Microrna Associated with Active Systemic Juvenile Idiopathic Arthritis Regulate CD163 Expression in Polarized Macrophages through Two Distinct Mechanisms

Thuy Do1, Rachel Tan2, Mark Bennett2, Mario Medvedovic2, Nan Shen3, Sherry Thornton1, Alexei Grom1 and Grant Schulert4, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2University of Cincinnati, Cincinnati, OH, 3Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Macrophage, MicroRNA, Systemic JIA and monocytes

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Pediatric Rheumatology – Pathogenesis and Genetics - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  CD163 is a hemoglobin scavenger receptor and innate pattern recognition receptor, and a marker of activated monocytes and macrophages. It is also expressed on monocytes from children with active systemic juvenile idiopathic arthritis, and associated with emergence of macrophage activation syndrome. However, the regulation of CD163 expression during monocyte and macrophage polarization is poorly understood. MicroRNA post-transcriptionally regulate gene expression, often serving as feedback loops to “fine tune” gene expression programs. We hypothesize that microRNA dysregulated in active SJIA modulate expression of CD163 in polarized macrophage populations

Methods:  Human THP-1 monocytic cells and primary monocytes and monocyte-derived macrophages from healthy donors were polarized in vitro. CD163 expression was determined by quantitative RT-PCR or on a single-cell level by RNA flow cytometry using the PrimeFlow kit. Cells were also transfected with specific microRNA mimics or antagomirs to miR-125a-5p, miR-181a or miR-181c. Direct binding of miR-181 family members to the CD163 3’ untranslated region (UTR) was determined using a luciferase reporter system and through RNA immunoprecipitation (RIP). RNA-sequencing was used to identify differentially regulated genes in macrophages overexpressing miR-125a-5p or control mimics.

Results:  Significantly increased CD163 mRNA levels were detected only in monocytes and macrophages polarized towards M2c conditions by IL-10. Similarly, single-cell analysis showed markedly increased CD163 surface protein and mRNA levels only with IL-10 treatment. Several candidate microRNA which are overexpressed in monocytes from children with active systemic JIA may regulate CD163. Here, we find that overexpression of miR-125a-5p and miR-181c significantly reduced CD163 mRNA expression in IL-10 polarized macrophages. In vitro, both miR-125a and miR-181 family members were elevated in polarizing conditions that restrict CD163 expression, and inhibition of these with antagomirs increased CD163 mRNA levels. Interestingly, these microRNAs regulated CD163 expression through distinct mechanisms. Computationally, miR-181 is predicted to bind directly to the 3’ UTR of CD163 mRNA. Using both a luciferase reporter system and RIP assay we found direct interaction between miR-181 family members and the CD163 mRNA. In contrast, CD163 does not have a predicted miR-125a binding site. RNA-seq based genome wide target analysis identified “Cytokine-cytokine receptor interactions” as the most significantly repressed gene pathway upon miR-125a overexpression, and specifically decreased levels of IL10RA and TGFbR2. This finding suggests that miR-125a exerts global effects on macrophages to modulate polarization.

Conclusion:  Taken together, these data show that microRNAs regulate the IL-10-induced expression of CD163 in human macrophages through distinct mechanisms, directly targeting of CD163 mRNA and indirectly inhibiting cytokine receptor expression. These findings highlight the diverse ways microRNA regulatory networks affect macrophage polarization and phenotype in active SJIA.


Disclosure: T. Do, None; R. Tan, None; M. Bennett, None; M. Medvedovic, None; N. Shen, None; S. Thornton, None; A. Grom, Novartis Pharmaceutical Corporation, 5,novimmune, 5; G. Schulert, Novartis Pharmaceutical Corporation, 5.

To cite this abstract in AMA style:

Do T, Tan R, Bennett M, Medvedovic M, Shen N, Thornton S, Grom A, Schulert G. Microrna Associated with Active Systemic Juvenile Idiopathic Arthritis Regulate CD163 Expression in Polarized Macrophages through Two Distinct Mechanisms [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/microrna-associated-with-active-systemic-juvenile-idiopathic-arthritis-regulate-cd163-expression-in-polarized-macrophages-through-two-distinct-mechanisms/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microrna-associated-with-active-systemic-juvenile-idiopathic-arthritis-regulate-cd163-expression-in-polarized-macrophages-through-two-distinct-mechanisms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology